Thoracic Cancer

Papers
(The H4-Index of Thoracic Cancer is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information251
Issue Information63
Issue Information47
Correction to “The Prevalence, Distribution, and Clinicopathological Features of Seven Lung Cancer Actionable Driver Mutations in Taiwan”40
Issue Information39
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases38
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma37
Issue Information34
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report32
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report31
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report28
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma27
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema25
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche25
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements25
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report24
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 124
Issue Information24
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring 23
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer23
Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer23
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation 22
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor22
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China22
0.87365913391113